JNJ-78306358, a novel bispecific antibody with HLA-G expression-dependent antitumor activity April 22, 2022 No Comments
Tarus Therapeutics targets adenosine A2A/A2B receptors with compounds TT-10 and TT-4 April 21, 2022 No Comments
Antengene presents anti-CLDN18.2 ATG-022 for the treatment of gastric cancer April 20, 2022 No Comments
Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22 April 19, 2022 No Comments
RSS